Authors :
Ife U. F.; Toryila J. E.; Mallo M. J.
Volume/Issue :
Volume 11 - 2026, Issue 1 - January
Google Scholar :
https://tinyurl.com/3f64m9d3
Scribd :
https://tinyurl.com/2w9rrpmd
DOI :
https://doi.org/10.38124/ijisrt/26jan159
Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.
Abstract :
Background:
Gmelina arborea is traditionally used for managing inflammatory and immune-related disorders, yet scientific
validation of its immunomodulatory activity remains limited. This study evaluated the immunomodulatory effects of
ethanolic root extract of Gmelina arborea in Wistar rats.
Methods:
A controlled experimental design was used involving five groups of Wistar rats. Group 1 served as the negative control.
Group 2 received 20 mg/kg levamisole as the positive control. Groups 3–5 received 20 mg/kg levamisole followed by 50, 100,
and 150 mg/kg of Gmelina arborea extract for 28 days, with levamisole administered 12 hours before the extract.
Inflammatory markers, leukocyte indices, platelet parameters, and spleen histology were assessed.
Results:
Levamisole significantly increased IL-6 and ESR, confirming immunosuppression, while co-administration of Gmelina
arborea produced dose-dependent amelioration. The 150 mg/kg group showed IL-6 and CRP levels comparable to the
negative control and restored leukocyte and granulocyte balance. Platelet indices revealed improved hematopoietic stability
and white pulp architecture.
Conclusion:
Gmelina arborea demonstrated notable immunomodulatory potential by regulating cytokine expression and supporting
leukocyte function. These findings provide scientific support for its traditional use and highlight its promise as a natural
immunomodulatory agent.
Keywords :
Gmelina arborea, Immunomodulatory, Wistar Rats
References :
- Chaudhary, S., Soni, N., Kumar, N., & Mehta, J. K. (2020). A comprehensive review on pharmacological and phytochemical aspects of Gmelina arborea Roxb. Journal of Drug Delivery and Therapeutics, 10(5), 318–323. https://doi.org/10.22270/jddt.v10i5.4373.
- Adesina, S. K. (2024). Ethnobotany, phytochemistry and pharmacology of Nigerian medicinal plants.Journal of Ethnopharmacology, 312, 115–142. https://doi.org/10.1016/j.jep.2024.115142
- Suneetha, P., Meenakshi, R., & Rajashekara. (2023). An updated review on Gmelina arborea Roxb. In Phytochemistry & Pharmacological Reviews (book chapter).
- Siddiqua, A., Ali, M., & Afzal, M. (2022). Phytochemical and pharmacological profile of Gmelina arborea Roxb.: A comprehensive review. Journal of Ethnopharmacology, 292, 115–126. https://doi.org/10.1016/j.jep.2022.115126
- Nguyen, A., Smith, J., & Clarke, R. (2024). Immunostimulatory pathways involving pattern recognition receptors and cytokine signaling. Journal of Immunological Research, 48(2), 115-129.
- Bamidele, T. A., Adekunle, A. S., & Akinloye, O. (2022). Hematological and immunomodulatory effects of Gmelina arborea root extract in Wistar rats. Journal of Medicinal Plant Research, 16(2), 45–53. https://doi.org/10.5897/JMPR2022.7123
- Srinivasan, R., & Subramaniam, S. (2023). Immunomodulatory effects of ethanolic extract of Gmelina arborea in experimental models. International Journal of Immunopharmacology,45(2),112–120. https://doi.org/10.1016/j.ijiph.2023.112120
- Olanrewaju, J. A., Adebayo, S. E., & Ogunyemi, A. O. (2022). Herbal immunomodulators and their role in inflammatory biomarker regulation: A review of C-reactive protein (CRP) modulation. African Journal of Traditional, Complementary and Alternative Medicines, 19(4), 112–124.
- Afolayan, A. J., Adeyemi, T., & Oladipo, O. (2023). Flavonoid-rich plant extracts as inhibitors of IL-6 mediated inflammation: A study on Gmelina arborea root extract. Journal of Inflammatory Disorders, 18(3), 210–222. https://doi.org/10.1016/j.jid.2023.03.005
Background:
Gmelina arborea is traditionally used for managing inflammatory and immune-related disorders, yet scientific
validation of its immunomodulatory activity remains limited. This study evaluated the immunomodulatory effects of
ethanolic root extract of Gmelina arborea in Wistar rats.
Methods:
A controlled experimental design was used involving five groups of Wistar rats. Group 1 served as the negative control.
Group 2 received 20 mg/kg levamisole as the positive control. Groups 3–5 received 20 mg/kg levamisole followed by 50, 100,
and 150 mg/kg of Gmelina arborea extract for 28 days, with levamisole administered 12 hours before the extract.
Inflammatory markers, leukocyte indices, platelet parameters, and spleen histology were assessed.
Results:
Levamisole significantly increased IL-6 and ESR, confirming immunosuppression, while co-administration of Gmelina
arborea produced dose-dependent amelioration. The 150 mg/kg group showed IL-6 and CRP levels comparable to the
negative control and restored leukocyte and granulocyte balance. Platelet indices revealed improved hematopoietic stability
and white pulp architecture.
Conclusion:
Gmelina arborea demonstrated notable immunomodulatory potential by regulating cytokine expression and supporting
leukocyte function. These findings provide scientific support for its traditional use and highlight its promise as a natural
immunomodulatory agent.
Keywords :
Gmelina arborea, Immunomodulatory, Wistar Rats